Mustapha Musa
Probing the Mechanism of Action of Bis(phenolato) Amine (ONO Donor Set) Titanium(IV) Anticancer Agents
Musa, Mustapha; Abid, Mohammed; Bradshaw, Tracey D.; Boocock, David J.; Coveney, Clare; Argent, Stephen P.; Woodward, Simon
Authors
Mohammed Abid
Dr TRACEY BRADSHAW tracey.bradshaw@nottingham.ac.uk
Associate Professor
David J. Boocock
Clare Coveney
STEPHEN ARGENT stephen.argent@nottingham.ac.uk
Senior Research Fellow
SIMON WOODWARD simon.woodward@nottingham.ac.uk
Professor of Synthetic Organic Chemistry
Abstract
The need for anticancer therapies that overcome metallodrug resistance while minimizing adverse toxicities is targeted, herein, using titanium coordination complexes. Octahedral titanium(IV) trans, mer-[Ti{R1N(CH2–2-MeO-4-R1-C6H2)2}2] [R1 = Et, allyl, n-Pr, CHO, F, CH2(morpholino), the latter from the formyl derivative; R2 = Me, Et; not all combinations] are attained from Mannich reactions of commercial 2-methoxyphenols (27–74% overall yield, 2 steps). These crystalline (four X-ray structures) Ti(IV)-complexes are active against MCF-7, HCT-116, HT-29, PANC-1, and MDA-MB-468 cancer cell lines (GI50 = 0.5–38 μM). Their activity and cancer selectivity (vs nontumor MRC-5 cells) typically exceeds that of cisplatin (up to 16-fold). Proteomic analysis (in MCF-7) supported by other studies (G2/M cell cycle arrest, ROS generation, γH2AX production, caspase activation, annexin positivity, western blot, and kinase screens in MCF-7 and HCT-116) suggest apoptosis elicited by more than one mechanism of action. Comparison of these data to the modes of action proposed for salan Ti(IV) complexes is made.
Journal Article Type | Article |
---|---|
Acceptance Date | Jan 18, 2024 |
Online Publication Date | Feb 8, 2024 |
Publication Date | Feb 22, 2024 |
Deposit Date | Jan 22, 2024 |
Publicly Available Date | Feb 12, 2024 |
Journal | Journal of Medicinal Chemistry |
Print ISSN | 0022-2623 |
Electronic ISSN | 1520-4804 |
Publisher | American Chemical Society |
Peer Reviewed | Peer Reviewed |
Volume | 67 |
Issue | 4 |
Pages | 2732-2744 |
DOI | https://doi.org/10.1021/acs.jmedchem.3c01874 |
Keywords | titanium complexes, phenolate ligands, anti-cancer, mode of action, proteomics |
Public URL | https://nottingham-repository.worktribe.com/output/30109252 |
Publisher URL | https://pubs.acs.org/doi/10.1021/acs.jmedchem.3c01874 |
Files
musa-et-al-2024-probing-the-mechanism-of-action-of-bis(phenolato)-amine-(ono-donor-set)-titanium(iv)-anticancer-agents
(3.7 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
Copyright Statement
© 2024 The Authors. Published by American Chemical Society. This publication is licensed under CC-BY 4.0.
You might also like
Highly electron deficient diketopyrrolopyrroles
(2023)
Journal Article
In Vitro Anticancer Properties of Novel Bis-Triazoles
(2022)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search